Using siRNA-Based Anti-Inflammatory Lipid Nanoparticles for Gene Regulation in Psoriasis
International Journal of Nanomedicine · 2025
DOI: 10.2147/ijn.s504639 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Aizhong Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211112, People's Republic of China. Hauptthemen laut MEDLINE: Psoriasis, RNA, Small Interfering, Nanoparticles, Anti-Inflammatory Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211112, People's Republic of China.
Zitieren
APA
Zeng, A., Liu, Y., Wang, P., Cao, Y., & Guo, W. (2025). Using siRNA-Based Anti-Inflammatory Lipid Nanoparticles for Gene Regulation in Psoriasis. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s504639
Vancouver
Zeng A, Liu Y, Wang P, Cao Y, Guo W. Using siRNA-Based Anti-Inflammatory Lipid Nanoparticles for Gene Regulation in Psoriasis. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s504639
BibTeX
@article{Zeng2025,
author = {Zeng, Aizhong and Liu, Yuanyuan and Wang, Ping and Cao, Yufei and Guo, Wei},
title = {Using siRNA-Based Anti-Inflammatory Lipid Nanoparticles for Gene Regulation in Psoriasis},
journal = {International Journal of Nanomedicine},
year = {2025},
doi = {10.2147/ijn.s504639}
}
EUVIMED